Scott Mlyn | CNBC
Brendan Kennedy, CEO, Tilray
Canadian cannabis company Tilray entered a $100 million joint venture with beer brewer AB InBev to study non-alcoholic THC and CBD beverages, the companies announced Wednesday.
The partnership is limited to Canada, and the companies will make decisions about commercializing the products in the future. Shares of Tilray jumped 13 percent after hours.
On Tuesday, Tilray announced a partnership with Novartis unit Sandoz to produce and distribute medical cannabis products. News of the deal sent Tilray shares soaring as much as 22 percent. They fell more than 6 percent Wednesday.
News & Media, page-12
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
